|
Study to evaluate immunogenicity and safety of GSK Bios’ MeMuRu-OKA vaccine compared to concomitant administrations of GSK Bios’ Priorix™ and Varilrix™ vaccines |
Combined Measles, Mumps, Rubella, Varicella Vaccine |
208136/018 (MeMuRu-OKA-018) |
|
Measles; Mumps; Rubella; Varicella |
Phase 3 |
|
|
|
|
An annotated case report form is not available for this study. A blank case report form will be provided. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. |
September 2015 |